Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Barriers to treatment optimization and achievement of patients’ goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry

Fig. 4

Treatment change in participants with RAPID3 high disease activity scores. Results show the proportion of participants with high disease activity, as measured by RAPID3 (> 12.0)11, who accepted or declined a treatment change when it was offered by their physician. RAPID3 Routine Assessment of Patient Index Data 3, REM remission

Back to article page